These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17684810)

  • 1. Diabetes update 2006: urgency for new approaches.
    Gavin JR
    Ethn Dis; 2007; 17(2 Suppl 2):S2-23-7. PubMed ID: 17684810
    [No Abstract]   [Full Text] [Related]  

  • 2. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
    Sacks FM
    Am J Cardiol; 2008 Dec; 102(12A):1L-3L. PubMed ID: 19084082
    [No Abstract]   [Full Text] [Related]  

  • 3. Contemporary approaches for cardiovascular risk reduction in diabetes.
    Deedwania P
    Indian Heart J; 2009; 61(1):24-33. PubMed ID: 19729685
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetes: one part of the cardiovascular problem post-transplant.
    Luxon A; First MR
    Nephrol News Issues; 2006 Sep; 20(10):33-4. PubMed ID: 16977919
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diabetes screening and early therapy. Feasible and successful].
    MMW Fortschr Med; 2010 Oct; 152(40):16. PubMed ID: 21053403
    [No Abstract]   [Full Text] [Related]  

  • 6. Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association.
    Marwick TH; Hordern MD; Miller T; Chyun DA; Bertoni AG; Blumenthal RS; Philippides G; Rocchini A; ; ; ; ;
    Circulation; 2009 Jun; 119(25):3244-62. PubMed ID: 19506108
    [No Abstract]   [Full Text] [Related]  

  • 7. Model-based benefit-risk assessment: can Archimedes help?
    Krishna R
    Clin Pharmacol Ther; 2009 Mar; 85(3):239-40. PubMed ID: 19223878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of macrovascular disease in patients with diabetes mellitus: opportunities for intervention.
    Mazzone T
    Am J Med; 2007 Sep; 120(9 Suppl 2):S26-32. PubMed ID: 17826043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Trends in diabetes].
    Ruiz J; Egli M
    Rev Med Suisse; 2008 Jan; 4(140):116, 118-21. PubMed ID: 18309874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of a pharmacist-led cardiovascular risk reduction clinic for diabetic patients with and without mental health conditions.
    Taveira TH; Pirraglia PA; Cohen LB; Wu WC
    Prev Cardiol; 2008; 11(4):195-200. PubMed ID: 19476571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expert perspective: reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering.
    Jones PH
    Am J Cardiol; 2008 Dec; 102(12A):41L-47L. PubMed ID: 19084089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flavanol-rich cocoa a promising new dietary intervention to reduce cardiovascular risk in type 2 diabetes?
    Campia U; Panza JA
    J Am Coll Cardiol; 2008 Jun; 51(22):2150-2. PubMed ID: 18510962
    [No Abstract]   [Full Text] [Related]  

  • 13. ADVANCE trial of great importance in preventing cardiovascular deaths in type 2 diabetes.
    Cardiovasc J Afr; 2007; 18(5):343-4. PubMed ID: 17985038
    [No Abstract]   [Full Text] [Related]  

  • 14. New insights into understanding cardiometabolic risk. Introduction.
    Fonarow GC; Watson KE
    Rev Cardiovasc Med; 2007; 8 Suppl 4():S1-2. PubMed ID: 17934389
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular disease and type 2 diabetes mellitus: a multifaceted symbiosis.
    Johansen OE
    Scand J Clin Lab Invest; 2007; 67(8):786-800. PubMed ID: 17852797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prevention of cardiovascular disease in people with dysglycemia.
    Bianchi C; Miccoli R; Penno G; Del Prato S
    Diabetes Care; 2008 Feb; 31 Suppl 2():S208-14. PubMed ID: 18227487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early insulin treatment to prevent cardiovascular disease in prediabetes and overt diabetes.
    Roman G; Hancu N
    Horm Metab Res; 2009 Feb; 41(2):116-22. PubMed ID: 19214921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [ACCORD (Action to Control Cardiovascular Risk in Diabetes trial) becoming "two-tone"].
    Seufert J
    Dtsch Med Wochenschr; 2008 May; 133(20):1068-70. PubMed ID: 18461525
    [No Abstract]   [Full Text] [Related]  

  • 19. Smokin' diabetes blues.
    Gottlieb SH
    Diabetes Forecast; 2002 Mar; 55(3):42-4. PubMed ID: 14959677
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid-lowering therapy in patients with type 2 diabetes: the case for early intervention.
    Steinmetz A
    Diabetes Metab Res Rev; 2008; 24(4):286-93. PubMed ID: 18273835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.